![Nektar Therapeutics](/common/images/company/L_0UNL.png)
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc 11-Oct-2022 / 14:01 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The...
Norges Bank - Form 8.3 - Nektar Therapeutics, Inc PR Newswire London, October 11 ...
L FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1...
L FORM 8.3 OPENING DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc 10-Oct-2022 / 14:21 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 47.18 | 47.18 | 47.18 | 157 | 47.18 | DE |
4 | 0 | 0 | 47.18 | 47.18 | 47.18 | 2457 | 47.18 | DE |
12 | 0 | 0 | 47.18 | 47.18 | 47.18 | 9609 | 47.18 | DE |
26 | 0 | 0 | 47.18 | 47.18 | 47.18 | 7122 | 47.18 | DE |
52 | 0 | 0 | 47.18 | 47.18 | 47.18 | 9279 | 47.18 | DE |
156 | 0 | 0 | 47.18 | 47.18 | 47.18 | 6934 | 47.18 | DE |
260 | 0 | 0 | 47.18 | 47.18 | 47.18 | 4256 | 47.18 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales